How LIR Life Sciences is making GLP-1 therapy easier to access worldwide

LIR Life Sciences is a leader in the dvancement of novel, needle-free drug delivery platforms for obesity treatment across ...
PharmiWeb

BioNxt Accelerates ODF for Multiple Sclerosis Toward Human Clinical Study with >40% Bioavailability Improvement and Myasthenia Gravis Expansion

VANCOUVER, BC / ACCESS Newswire / January 26, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

BioNxt Solutions Inc.: BioNxt Accelerates ODF for Multiple Sclerosis Toward Human Clinical Study with >40% Bioavailability Improvement and Myasthenia Gravis Expansion

VANCOUVER, BC / ACCESS Newswire / January 26, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery s ...

Optimized solvent conditions improve drug retention and targeting in lymph node metastasis

Optimizing drug delivery to the lymphatic system is essential for effective cancer treatment, as lymph node (LN) metastasis ...
AlphaGalileo

Optimized Solvent Design Improves Lymphatic Drug Delivery to Metastatic Lymph Nodes

Lymphatic Drug Delivery System (LDDS) is an emerging type of cancer treatment, but its efficacy depends on how efficiently ...